Barclays’s PDL BioPharma, Inc. PDLI Stock Holding History

Barclays’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,800	Closed	-$4K	–	7258
2016 Q4	$4K	Buy	1,800 +1,600	+800%	+$4.46K	﹤0.01%	6235
2016 Q3	$1K	Sell	200 -55,700	-100%	-$177K	﹤0.01%	6559
2016 Q2	$176K	Sell	55,900 -14,000	-20%	-$46.7K	﹤0.01%	4009
2016 Q1	$210K	Buy	69,900 +66,000	+1,692%	+$206K	﹤0.01%	3818
2015 Q4	$12K	Buy	3,900 +2,300	+144%	+$9.63K	﹤0.01%	5365
2015 Q3	$8K	Buy	1,600 +200	+14%	+$1.15K	﹤0.01%	5899
2015 Q2	$8K	Sell	1,400 -6,700	-83%	-$44.9K	﹤0.01%	6244
2015 Q1	$57K	Buy	8,100 +400	+5%	+$2.9K	﹤0.01%	5193
2014 Q4	$54K	Buy	7,700 +1,900	+33%	+$15K	﹤0.01%	5669
2014 Q3	$41K	Sell	5,800 -90,300	-94%	-$838K	﹤0.01%	6040
2014 Q2	$865K	Sell	96,100 -105,600	-52%	-$941K	﹤0.01%	3468
2014 Q1	$1.61M	Sell	201,700 -96,200	-32%	-$825K	﹤0.01%	2760
2013 Q4	$2.38M	Buy	297,900 +51,400	+21%	+$433K	﹤0.01%	2486
2013 Q3	$1.73M	Buy	246,500 +193,100	+362%	+$1.55M	﹤0.01%	2759
2013 Q2	$412K	Buy	+53,400	New	+$416K	﹤0.01%	4442

Other funds holding PDLI

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

Barclays's PDLI Position: Q1 2021 in Review

Barclays sold out of PDL BioPharma, Inc. (PDLI) in Q1 2021, closing a stake of 596 shares — an estimated $1K sold.

Barclays first reported a position in PDLI in Q2 2013 and held it in 31 quarters. The position peaked at $1.82M in Q2 2014. 11 funds tracked by Wall St. Rank hold PDLI as of Q1 2021.

Barclays reported no remaining PDL BioPharma, Inc. position as of Q1 2021 after selling out during the quarter.
Barclays sold 596 PDL BioPharma, Inc. shares in Q1 2021, an estimated $1K.
Barclays first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 31 quarters.
Barclays's PDL BioPharma, Inc. position peaked at $1.82M in Q2 2014.
11 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2021.

Based on Barclays's 13F filing for Q1 2021, filed 13 May 2021.